back to cluster viewer
cluster path 0011111100001101
102 words, 9,327 tokens
freq alpha suffix
Words in frequency order
1 | pathway | 8,146
|
2 | cascade | 1,001
|
3 | disruptant | 15
|
4 | variate | 15
|
5 | ch | 8
|
6 | 3,4-dioxygenase | 7
|
7 | afterimage | 5
|
8 | 9/3 | 4
|
9 | gperad | 4
|
10 | c-dependent | 3
|
11 | contract* | 3
|
12 | convertor | 3
|
13 | crosspoint | 3
|
14 | deadenylase | 3
|
15 | funnels | 3
|
16 | h_9 | 3
|
17 | hemichannel | 3
|
18 | modulator-3 | 3
|
19 | py216 | 3
|
20 | transinteraction | 3
|
21 | 8-phosphate | 2
|
22 | c161 | 2
|
23 | hydrolysis-mild | 2
|
24 | immunonegative | 2
|
25 | series-type | 2
|
26 | vitreolysis | 2
|
27 | ι-carrageenase | 2
|
28 | -inflammasome | 1
|
29 | 1,4-dioxo | 1
|
30 | 2015:63:906-920 | 1
|
31 | achaea | 1
|
32 | allenylation | 1
|
33 | amination-based | 1
|
34 | aspirin-ace | 1
|
35 | auto-cleavage | 1
|
36 | autotranscription | 1
|
37 | betaadrenergic | 1
|
38 | biooxidations | 1
|
39 | brain-rhythms | 1
|
40 | c217 | 1
|
41 | channel/antiporter | 1
|
42 | condensation/enamine | 1
|
43 | coupling/wacker-type | 1
|
44 | deglucuronization | 1
|
45 | flyways | 1
|
46 | fourfolds | 1
|
47 | gadphs | 1
|
48 | gene-therapy | 1
|
49 | genes-buda | 1
|
50 | glnb | 1
|
51 | gradients-involving | 1
|
52 | greenbelts | 1
|
53 | h6cdds | 1
|
54 | hslvs | 1
|
55 | hypermorph | 1
|
56 | i2-pph3 | 1
|
57 | ic50=1.79μm | 1
|
58 | immunoblotings | 1
|
59 | inhibitor-3ma | 1
|
60 | inhibitortacrine | 1
|
61 | isomerisms | 1
|
62 | ligand-dependently | 1
|
63 | loss=1 | 1
|
64 | lrp5/6 | 1
|
65 | machine-discriminant | 1
|
66 | myofasciitis | 1
|
67 | nek8 | 1
|
68 | neosynthesized | 1
|
69 | noninnnocent | 1
|
70 | over-activation-induced | 1
|
71 | overexpression-neoplasia | 1
|
72 | overexpression.16 | 1
|
73 | parthway | 1
|
74 | pathway-controlling | 1
|
75 | pathway-one | 1
|
76 | pathways.finally | 1
|
77 | pathways—jnk | 1
|
78 | pi3k-isoforms | 1
|
79 | pik3c3/vps34 | 1
|
80 | presentation-associated | 1
|
81 | product-sarcosine | 1
|
82 | protein-gok1 | 1
|
83 | pser19 | 1
|
84 | riok1 | 1
|
85 | rs27653 | 1
|
86 | rs6450512 | 1
|
87 | rs705379 | 1
|
88 | s58d | 1
|
89 | s608 | 1
|
90 | ser236cys | 1
|
91 | shakeoff | 1
|
92 | specks | 1
|
93 | stimuli/antigens | 1
|
94 | substrates/inhibitors | 1
|
95 | threshold-regulated | 1
|
96 | tyr-385 | 1
|
97 | ubinuclein1 | 1
|
98 | uprergulation | 1
|
99 | val742ala | 1
|
100 | zyg-1/sak/plk4 | 1
|
101 | ß-subunits | 1
|
102 | σ-70 | 1
|
Words in alphabetical order
1 | -inflammasome | 1
|
2 | 1,4-dioxo | 1
|
3 | 2015:63:906-920 | 1
|
4 | 3,4-dioxygenase | 7
|
5 | 8-phosphate | 2
|
6 | 9/3 | 4
|
7 | achaea | 1
|
8 | afterimage | 5
|
9 | allenylation | 1
|
10 | amination-based | 1
|
11 | aspirin-ace | 1
|
12 | auto-cleavage | 1
|
13 | autotranscription | 1
|
14 | betaadrenergic | 1
|
15 | biooxidations | 1
|
16 | brain-rhythms | 1
|
17 | c-dependent | 3
|
18 | c161 | 2
|
19 | c217 | 1
|
20 | cascade | 1,001
|
21 | channel/antiporter | 1
|
22 | condensation/enamine | 1
|
23 | contract* | 3
|
24 | convertor | 3
|
25 | coupling/wacker-type | 1
|
26 | crosspoint | 3
|
27 | ch | 8
|
28 | deadenylase | 3
|
29 | deglucuronization | 1
|
30 | disruptant | 15
|
31 | flyways | 1
|
32 | fourfolds | 1
|
33 | funnels | 3
|
34 | gadphs | 1
|
35 | gene-therapy | 1
|
36 | genes-buda | 1
|
37 | glnb | 1
|
38 | gperad | 4
|
39 | gradients-involving | 1
|
40 | greenbelts | 1
|
41 | h6cdds | 1
|
42 | h_9 | 3
|
43 | hemichannel | 3
|
44 | hslvs | 1
|
45 | hydrolysis-mild | 2
|
46 | hypermorph | 1
|
47 | i2-pph3 | 1
|
48 | ic50=1.79μm | 1
|
49 | immunoblotings | 1
|
50 | immunonegative | 2
|
51 | inhibitor-3ma | 1
|
52 | inhibitortacrine | 1
|
53 | isomerisms | 1
|
54 | ligand-dependently | 1
|
55 | loss=1 | 1
|
56 | lrp5/6 | 1
|
57 | machine-discriminant | 1
|
58 | modulator-3 | 3
|
59 | myofasciitis | 1
|
60 | nek8 | 1
|
61 | neosynthesized | 1
|
62 | noninnnocent | 1
|
63 | over-activation-induced | 1
|
64 | overexpression-neoplasia | 1
|
65 | overexpression.16 | 1
|
66 | parthway | 1
|
67 | pathway | 8,146
|
68 | pathway-controlling | 1
|
69 | pathway-one | 1
|
70 | pathways.finally | 1
|
71 | pathways—jnk | 1
|
72 | pi3k-isoforms | 1
|
73 | pik3c3/vps34 | 1
|
74 | presentation-associated | 1
|
75 | product-sarcosine | 1
|
76 | protein-gok1 | 1
|
77 | pser19 | 1
|
78 | py216 | 3
|
79 | riok1 | 1
|
80 | rs27653 | 1
|
81 | rs6450512 | 1
|
82 | rs705379 | 1
|
83 | s58d | 1
|
84 | s608 | 1
|
85 | ser236cys | 1
|
86 | series-type | 2
|
87 | shakeoff | 1
|
88 | specks | 1
|
89 | stimuli/antigens | 1
|
90 | substrates/inhibitors | 1
|
91 | threshold-regulated | 1
|
92 | transinteraction | 3
|
93 | tyr-385 | 1
|
94 | ubinuclein1 | 1
|
95 | uprergulation | 1
|
96 | val742ala | 1
|
97 | variate | 15
|
98 | vitreolysis | 2
|
99 | zyg-1/sak/plk4 | 1
|
100 | ß-subunits | 1
|
101 | ι-carrageenase | 2
|
102 | σ-70 | 1
|
Words in suffix order
1 | contract* | 3
|
2 | 2015:63:906-920 | 1
|
3 | σ-70 | 1
|
4 | c161 | 2
|
5 | loss=1 | 1
|
6 | protein-gok1 | 1
|
7 | riok1 | 1
|
8 | ubinuclein1 | 1
|
9 | rs6450512 | 1
|
10 | modulator-3 | 3
|
11 | 9/3 | 4
|
12 | rs27653 | 1
|
13 | i2-pph3 | 1
|
14 | pik3c3/vps34 | 1
|
15 | zyg-1/sak/plk4 | 1
|
16 | tyr-385 | 1
|
17 | lrp5/6 | 1
|
18 | overexpression.16 | 1
|
19 | py216 | 3
|
20 | c217 | 1
|
21 | s608 | 1
|
22 | nek8 | 1
|
23 | pser19 | 1
|
24 | rs705379 | 1
|
25 | h_9 | 3
|
26 | genes-buda | 1
|
27 | achaea | 1
|
28 | overexpression-neoplasia | 1
|
29 | val742ala | 1
|
30 | inhibitor-3ma | 1
|
31 | glnb | 1
|
32 | betaadrenergic | 1
|
33 | s58d | 1
|
34 | gperad | 4
|
35 | over-activation-induced | 1
|
36 | amination-based | 1
|
37 | presentation-associated | 1
|
38 | threshold-regulated | 1
|
39 | neosynthesized | 1
|
40 | hydrolysis-mild | 2
|
41 | aspirin-ace | 1
|
42 | cascade | 1,001
|
43 | afterimage | 5
|
44 | auto-cleavage | 1
|
45 | -inflammasome | 1
|
46 | condensation/enamine | 1
|
47 | inhibitortacrine | 1
|
48 | product-sarcosine | 1
|
49 | pathway-one | 1
|
50 | coupling/wacker-type | 1
|
51 | series-type | 2
|
52 | deadenylase | 3
|
53 | ι-carrageenase | 2
|
54 | 3,4-dioxygenase | 7
|
55 | 8-phosphate | 2
|
56 | variate | 15
|
57 | immunonegative | 2
|
58 | shakeoff | 1
|
59 | pathway-controlling | 1
|
60 | gradients-involving | 1
|
61 | hypermorph | 1
|
62 | ch | 8
|
63 | pathways—jnk | 1
|
64 | hemichannel | 3
|
65 | ic50=1.79μm | 1
|
66 | uprergulation | 1
|
67 | allenylation | 1
|
68 | deglucuronization | 1
|
69 | transinteraction | 3
|
70 | autotranscription | 1
|
71 | 1,4-dioxo | 1
|
72 | channel/antiporter | 1
|
73 | convertor | 3
|
74 | h6cdds | 1
|
75 | fourfolds | 1
|
76 | immunoblotings | 1
|
77 | gadphs | 1
|
78 | vitreolysis | 2
|
79 | myofasciitis | 1
|
80 | specks | 1
|
81 | funnels | 3
|
82 | brain-rhythms | 1
|
83 | pi3k-isoforms | 1
|
84 | isomerisms | 1
|
85 | stimuli/antigens | 1
|
86 | biooxidations | 1
|
87 | substrates/inhibitors | 1
|
88 | ß-subunits | 1
|
89 | greenbelts | 1
|
90 | hslvs | 1
|
91 | flyways | 1
|
92 | ser236cys | 1
|
93 | machine-discriminant | 1
|
94 | disruptant | 15
|
95 | noninnnocent | 1
|
96 | c-dependent | 3
|
97 | crosspoint | 3
|
98 | pathway | 8,146
|
99 | parthway | 1
|
100 | pathways.finally | 1
|
101 | ligand-dependently | 1
|
102 | gene-therapy | 1
|